A detailed history of Martingale Asset Management L P transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Martingale Asset Management L P holds 40,265 shares of AMPH stock, worth $1.34 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
40,265
Previous 39,265 2.55%
Holding current value
$1.34 Million
Previous $1.57 Million 24.46%
% of portfolio
0.05%
Previous 0.03%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$36.99 - $50.09 $36,990 - $50,090
1,000 Added 2.55%
40,265 $1.95 Million
Q2 2024

Aug 12, 2024

SELL
$38.65 - $43.48 $309 - $347
-8 Reduced 0.02%
39,265 $1.57 Million
Q4 2023

Feb 12, 2024

SELL
$44.49 - $62.93 $22,600 - $31,968
-508 Reduced 1.28%
39,273 $2.43 Million
Q3 2023

Nov 14, 2023

SELL
$45.51 - $65.0 $81,098 - $115,830
-1,782 Reduced 4.29%
39,781 $1.83 Million
Q2 2023

Aug 11, 2023

SELL
$35.77 - $58.38 $21,640 - $35,319
-605 Reduced 1.43%
41,563 $2.39 Million
Q1 2023

May 12, 2023

SELL
$27.99 - $37.92 $111,400 - $150,921
-3,980 Reduced 8.62%
42,168 $1.58 Million
Q4 2022

Feb 13, 2023

SELL
$27.93 - $31.27 $541,506 - $606,262
-19,388 Reduced 29.58%
46,148 $1.29 Million
Q3 2022

Nov 14, 2022

SELL
$27.56 - $37.75 $249,087 - $341,184
-9,038 Reduced 12.12%
65,536 $1.84 Million
Q2 2022

Aug 11, 2022

SELL
$29.79 - $42.29 $255,061 - $362,086
-8,562 Reduced 10.3%
74,574 $2.59 Million
Q1 2022

May 12, 2022

SELL
$22.96 - $36.45 $433,163 - $687,665
-18,866 Reduced 18.5%
83,136 $2.98 Million
Q4 2021

Feb 11, 2022

SELL
$18.14 - $23.29 $144,847 - $185,970
-7,985 Reduced 7.26%
102,002 $2.38 Million
Q3 2021

Nov 12, 2021

BUY
$17.83 - $21.49 $1.08 Million - $1.3 Million
60,570 Added 122.57%
109,987 $2.09 Million
Q2 2021

Aug 13, 2021

BUY
$17.11 - $20.92 $513,300 - $627,600
30,000 Added 154.5%
49,417 $996,000
Q1 2021

May 13, 2021

SELL
$17.21 - $20.65 $5,163 - $6,195
-300 Reduced 1.52%
19,417 $355,000
Q4 2020

Feb 10, 2021

SELL
$17.76 - $21.24 $1.47 Million - $1.76 Million
-82,800 Reduced 80.77%
19,717 $396,000
Q3 2020

Nov 12, 2020

SELL
$17.99 - $22.22 $1.98 Million - $2.45 Million
-110,313 Reduced 51.83%
102,517 $1.92 Million
Q2 2020

Aug 10, 2020

BUY
$14.25 - $22.46 $185 - $291
13 Added 0.01%
212,830 $4.78 Million
Q1 2020

May 11, 2020

BUY
$12.66 - $20.08 $40,246 - $63,834
3,179 Added 1.52%
212,817 $3.16 Million
Q4 2019

Feb 10, 2020

SELL
$17.07 - $20.64 $82,038 - $99,195
-4,806 Reduced 2.24%
209,638 $4.04 Million
Q3 2019

Nov 13, 2019

BUY
$19.12 - $22.62 $262,058 - $310,029
13,706 Added 6.83%
214,444 $4.25 Million
Q2 2019

Aug 13, 2019

SELL
$18.92 - $22.96 $372,724 - $452,312
-19,700 Reduced 8.94%
200,738 $0
Q1 2019

May 08, 2019

BUY
$19.46 - $25.28 $324,826 - $421,973
16,692 Added 8.19%
220,438 $0
Q4 2018

Feb 11, 2019

BUY
$17.72 - $22.51 $1.74 Million - $2.21 Million
98,117 Added 92.89%
203,746 $4.05 Million
Q3 2018

Nov 09, 2018

BUY
$15.39 - $19.38 $1.63 Million - $2.05 Million
105,629 New
105,629 $0

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.64B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Martingale Asset Management L P Portfolio

Follow Martingale Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.